Aethlon Medical study links Long COVID biomarker to Hemopurifier
Go back to Aethlon Medical study links Long COVID biomarker to Hemopurifier| Aethlon Medical, Inc. (NASDAQ: AEMD) | Delayed: 6.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.32 | 52 Week High | $9.09 | |||
| Open | $6.32 | 52 Week Low | $4.02 | |||
| Day High | $6.32 | P/E | N/A | |||
| Day Low | $6.32 | EPS | $-0.05 | |||
| Volume | 5,601 | |||||

